2020 | IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses | JOURNAL OF HEPATOLOGY |
2021 | Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B | HEPATOLOGY RESEARCH |
2022 | Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2020 | Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C
| GUT AND LIVER |
2014 | Impact of Spontaneous Hepatocellular Carcinoma Rupture on Recurrence Pattern and Long-term Surgical Outcomes after Partial Hepatectomy | WORLD JOURNAL OF SURGERY |
2021 | Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | HEPATOLOGY INTERNATIONAL |
2017 | Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2016 | Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease. | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2022 | Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2015 | Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis | HEPATOLOGY |
2014 | Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Influence of Besifovir Dipivoxil Maleate Combined With L-Carnitine on Hepatic Steatosis in Patients With Chronic Hepatitis B
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2013 | Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
2019 | Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
| CLINICAL AND MOLECULAR HEPATOLOGY |
2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
2014 | Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma. | LIVER INTERNATIONAL |
2015 | Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization | DIGESTIVE AND LIVER DISEASE |
2013 | Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
| PLOS ONE |
2016 | Knockdown of HIF-1a and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells | APOPTOSIS |
2010 | Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B | HEPATOLOGY |
2012 | Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir | LIVER INTERNATIONAL |
2021 | Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2017 | Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection. | ONCOLOGY |
2014 | Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years
| WORLD JOURNAL OF SURGICAL ONCOLOGY |
2019 | Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
| GUT AND LIVER |
2022 | Liver Diseases in South Korea: A Pulse Check of the Public's Knowledge, Awareness, and Behaviors
| YONSEI MEDICAL JOURNAL |
2017 | Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke | ATHEROSCLEROSIS |
2019 | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients | CEREBROVASCULAR DISEASES |
2009 | Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2012 | Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation | DIGESTIVE DISEASES AND SCIENCES |
2009 | Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis | LIVER INTERNATIONAL |
2014 | Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
| PLOS ONE |
2015 | Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis | LIVER INTERNATIONAL |
2021 | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
| CANCERS |
2010 | Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
| ANTIVIRAL THERAPY |
2014 | Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir | LIVER INTERNATIONAL |
2005 | Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance | JOURNAL OF HEPATOLOGY |
2005 | Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2006 | Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex (Milican) for the Treatment of Small Hepatocellular Carcinoma
| CLINICAL CANCER RESEARCH |
2011 | Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2022 | Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2017 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
| CELL TRANSPLANTATION |
2007 | Long-term outcome of chronic hepatitis B based on histological grade and stage | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2014 | Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2022 | Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study | JOURNAL OF VIRAL HEPATITIS |
2019 | Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2015 | Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin | DIGESTIVE DISEASES AND SCIENCES |
2023 | Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
| JHEP REPORTS |
2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2022 | MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups | DIGESTIVE DISEASES AND SCIENCES |
2014 | Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy. | LIVER INTERNATIONAL |
2017 | Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
| GUT AND LIVER |
2020 | Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
| LANCET GASTROENTEROLOGY & HEPATOLOGY |
2008 | MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
| CARCINOGENESIS |
2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
2022 | Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study | DIABETES & METABOLISM |
2024 | Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease | GUT |
1999 | Mirizzi 증후군의 임상적 고찰
| Korean Journal of Pancreas and Biliary Tract |